Article
ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer
20 Aug 2022
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is a dismal disease with a 5-year survival rate of less than 10%, despite the recent advances in chemoradiotherapy. The sensitivity of the PDAC patients to chemoradiotherapy varies widely, especially to radiotherapy, suggesting the need for more elucidation of the underlying mechanisms. In this study, a novel function of the nuclear ITGA2, the alpha subunit of transmembrane...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
